文献速递前列腺癌

新诊断不利中危前列腺癌患者PSMA PET/CT检查适宜性——迈向基于肿瘤体积的风险分层

The appropriateness of PSMA PET/CT in newly diagnosed unfavorable intermediate-risk prostate cancer patients-towards a tumor volume-based risk stratification.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2024-09-23

本研究重新评估PSMA PET/CT在不列中危前列腺癌中的诊断价值,并验证荷兰前列腺癌网络(PCNN)亚分类。分析接受PSMA PET/CT的男性患者,评估转移性疾病发生率及其与PCNN亚组的相关性。结果显示12.4%的患者发现转移性疾病,较高PCNN亚组与转移潜能增加相关,低转移潜能病例的比值比显著较低(OR 0.19,95%CI 0.06-0.62;p=0.01),PCNN亚分类可减少48.1%的扫描负担。

要点

  • 12.4%的不利中危前列腺癌患者经PSMA PET/CT发现转移性疾病。
  • 较高PCNN亚组与转移潜能增加相关,低转移潜能病例OR为0.19(95%CI 0.06-0.62)。
  • PCNN亚分类可减少48.1%的扫描负担。

核心结论

  • 研究结果重申PSMA PET/CT在不列中危前列腺癌中的诊断价值,并验证PCNN亚分类可减少48.1%的扫描负担。

研究设计与样本

  • 本研究分析接受PSMA PET/CT的男性患者,评估转移性疾病发生率及其与PCNN亚组的相关性。

主要发现

  • 12.4%的患者发现转移性疾病。
  • 较高PCNN亚组与转移潜能增加相关;低转移潜能病例的比值比显著较低(OR 0.19,95%CI 0.06-0.62;p=0.01)。

关键数值与推荐

  • 低转移潜能病例的OR为0.19(95%CI 0.06-0.62;p=0.01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/OBJECTIVES: This study reassesses the diagnostic value of PSMA PET/CT in unfavorable intermediate-risk prostate cancer (PCa) and validates the Prostate Cancer Network the Netherlands (PCNN) subclassification. SUBJECTS/METHODS: Men subjected to PSMA PET/CT were analyzed, evaluating the incidence of metastatic disease and its correlation with PCNN subgroups. RESULTS: Metastatic disease was identified in 12.4% of patients. Higher PCNN subgroups correlated with increased metastatic potential; odds were significantly lower in low metastatic potential cases (OR: 0.19, 95% CI 0.06-0.62; p = 0.01). CONCLUSIONS: Our findings reaffirm PSMA PET/CT's diagnostic value in unfavorable intermediate-risk PCa and validate the PCNN subclassification, reducing scan burden by 48.1%.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Hagens MJ, Luining WI, Boevé LMS, et al. The appropriateness of PSMA PET/CT in newly diagnosed unfavorable intermediate-risk prostate cancer patients-towards a tumor volume-based risk stratification. Prostate Cancer Prostatic Dis. 2024. PMID: 39313655. doi:10.1038/s41391-024-00899-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。